TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2018. The put-call ratio across all filers is 5.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $17,000 | -71.2% | 35,000 | -20.5% | 0.00% | -66.7% |
| Q1 2019 | $59,000 | +18.0% | 44,000 | 0.0% | 0.01% | +20.0% |
| Q4 2018 | $50,000 | -58.7% | 44,000 | 0.0% | 0.01% | -54.5% |
| Q3 2018 | $121,000 | -22.9% | 44,000 | 0.0% | 0.01% | -21.4% |
| Q2 2018 | $157,000 | +18.9% | 44,000 | +2.3% | 0.01% | +16.7% |
| Q1 2018 | $132,000 | -30.2% | 43,000 | +43.3% | 0.01% | -29.4% |
| Q4 2017 | $189,000 | -7.8% | 30,000 | 0.0% | 0.02% | -10.5% |
| Q3 2017 | $205,000 | -4.2% | 30,000 | 0.0% | 0.02% | -9.5% |
| Q2 2017 | $214,000 | -22.5% | 30,000 | 0.0% | 0.02% | -22.2% |
| Q1 2017 | $276,000 | +128.1% | 30,000 | 0.0% | 0.03% | +125.0% |
| Q4 2016 | $121,000 | +31.5% | 30,000 | +25.0% | 0.01% | +50.0% |
| Q3 2016 | $92,000 | -10.7% | 24,000 | 0.0% | 0.01% | -11.1% |
| Q2 2016 | $103,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
| Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
| DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
| Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
| A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
| FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
| Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
| Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
| Man Group plc | 737,715 | $2,634,000 | 0.01% |